MarketPulse
N

$NUVB

3 articles found
1 positive
2 negative
0 neutral
BenzingaBenzinga··Schall Law Firm

Nuvation Bio Stock Plummets 25% as Fraud Probe Launches Over IBTROZI Disclosure

Schall Law Firm investigates $NUVB for potential securities violations after revealing 75% treatment discontinuations in oncology therapy, triggering sharp stock decline.
NUVBstock declinemisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

PayPal Faces Class Action Lawsuit After Earnings Miss, CEO Exit, and Guidance Withdrawal

PayPal faces class action lawsuit following Q4 2025 earnings miss, CEO departure, and withdrawn 2027 guidance amid operational challenges.
SNOWPYPLNUVBsecurities fraudclass action lawsuit
BenzingaBenzinga··Prnewswire

Biotech Pipeline Expands Arsenal Against Treatment-Resistant Cancers

Biotech firms advance treatment-resistant cancer therapies across multiple platforms, including oncolytic viruses and cellular immunotherapy, with several candidates achieving regulatory milestones and encouraging clinical data.
IBRXONCYNVCRCATXNUVBcolorectal cancerFDA approval